Overall, this study not only revealed the underlying mechanisms by which TAMs promoted PCSCs but also uncovered TAMs/CCL5 as a novel target in predicting prostate cancer prognosis and inhibiting prostate cancer metastasis. This evidence concerns the gene CCL5 and prostate carcinoma.